July 2019
Volume 60, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2019
N-isopropylacrylamide-based cellular scaffold for retinal pigment epithelial cells
Author Affiliations & Notes
  • Nicole Marie Amaral
    McMaster University, Hamilton, Ontario, Canada
  • Megan Dodd
    McMaster University, Hamilton, Ontario, Canada
  • Talena Rambarran
    McMaster University, Hamilton, Ontario, Canada
  • Heather Sheardown
    McMaster University, Hamilton, Ontario, Canada
  • Footnotes
    Commercial Relationships   Nicole Amaral, None; Megan Dodd, None; Talena Rambarran, None; Heather Sheardown, None
  • Footnotes
    Support  Ontario Research Func (C20/20: Responsive Materials for Ocular Therapy)
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 1922. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Nicole Marie Amaral, Megan Dodd, Talena Rambarran, Heather Sheardown; N-isopropylacrylamide-based cellular scaffold for retinal pigment epithelial cells. Invest. Ophthalmol. Vis. Sci. 2019;60(9):1922.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Age related macular degeneration (AMD) remains a world leading cause of irreversible central vision loss. In cases of late stage (wet) AMD, growth of blood vessels into the retina can lead to severe blindness. Early stage (dry) AMD is more common but is generally untreatable. There is widespread agreement that RPE degeneration lies at the core of AMD pathogenesis. RPE cells are responsible for maintaining the blood-retinal microenvironment by clearing debris through phagocytosis, producing growth factors that maintain the photoreceptors, and orchestrating cellular responses to stimuli. As dysfunctional RPE tends to occur prior to photoreceptor damage, it is believed that replenishing the RPE may have protective benefits. However, cell delivery through bolus injection has proven to be inefficient due to leakage, aggregation, and cell death. While solid scaffolds are often too rigid and bulky for application in the layers of the retina. Therefore, a thermoresponsive injectable hydrogel scaffold is explored for its potential as an RPE cellular scaffold.

Methods : As shown in Figure 1, a NIPAAm-based injectable previously developed in the Sheardown lab has been modified with RGDS, the adhesion peptide found in fibronectin of the extracellular matrix, on the N-acryloxysuccinimide copolymer. The modified material was characterized with nuclear magnetic resonance imaging (NMR). The viability of human retinal pigment epithelial cells (ARPE-19) cultured on the modified material is assessed.

Results : NMR confirmed modification of N-acryloxysuccinimide indicative of RGDS binding. Preliminary results, shown in Figure 2, in which ARPE-19 cells were cultured on thin layers of the modified hydrogel display moderate viability following 48h culture on phosphate buffered saline (PBS) and fibronectin (FN) modified formulations. Cells did not display strong viability on the unmodified NIPAAm-based material.

Conclusions : The development of a hydrogel scaffold primed for RPE cell adhesion has been characterized. Further studies exploring RPE integration and viability with the formed scaffold are required. If said scaffold can successfully be applied within the delicate layers of the retina, this hydrogel may present as a suitable method for cell delivery for various retinal pathologies such as AMD.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

 

Figure 1: Thermoresponsive hydrogel scaffolds for RPE delivery.

Figure 1: Thermoresponsive hydrogel scaffolds for RPE delivery.

 

Figure 2: ARPE-19 cell viability in LIVE/DEAD stained 2D cultures.

Figure 2: ARPE-19 cell viability in LIVE/DEAD stained 2D cultures.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×